Windtree Therapeutics (WINT) Competitors $1.64 -0.06 (-3.53%) Closing price 03/27/2025 04:00 PM EasternExtended Trading$1.66 +0.03 (+1.52%) As of 03/27/2025 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock WINT vs. SNOA, ENSC, ONVO, PWUP, KZIA, CPHI, CMND, ADIL, APM, and CELZShould you be buying Windtree Therapeutics stock or one of its competitors? The main competitors of Windtree Therapeutics include Sonoma Pharmaceuticals (SNOA), Ensysce Biosciences (ENSC), Organovo (ONVO), PowerUp Acquisition (PWUP), Kazia Therapeutics (KZIA), China Pharma (CPHI), Clearmind Medicine (CMND), Adial Pharmaceuticals (ADIL), Aptorum Group (APM), and Creative Medical Technology (CELZ). These companies are all part of the "pharmaceutical products" industry. Windtree Therapeutics vs. Sonoma Pharmaceuticals Ensysce Biosciences Organovo PowerUp Acquisition Kazia Therapeutics China Pharma Clearmind Medicine Adial Pharmaceuticals Aptorum Group Creative Medical Technology Sonoma Pharmaceuticals (NASDAQ:SNOA) and Windtree Therapeutics (NASDAQ:WINT) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, media sentiment, valuation, community ranking, dividends, earnings, institutional ownership and analyst recommendations. Do insiders & institutionals believe in SNOA or WINT? 2.0% of Sonoma Pharmaceuticals shares are held by institutional investors. Comparatively, 29.3% of Windtree Therapeutics shares are held by institutional investors. 3.9% of Sonoma Pharmaceuticals shares are held by company insiders. Comparatively, 0.3% of Windtree Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has preferable earnings and valuation, SNOA or WINT? Sonoma Pharmaceuticals has higher revenue and earnings than Windtree Therapeutics. Sonoma Pharmaceuticals is trading at a lower price-to-earnings ratio than Windtree Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSonoma Pharmaceuticals$13.97M0.33-$4.84M-$4.02-0.72Windtree TherapeuticsN/AN/A-$20.29M-$823.470.00 Is SNOA or WINT more profitable? Windtree Therapeutics has a net margin of 0.00% compared to Sonoma Pharmaceuticals' net margin of -26.82%. Sonoma Pharmaceuticals' return on equity of -68.98% beat Windtree Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Sonoma Pharmaceuticals-26.82% -68.98% -26.39% Windtree Therapeutics N/A -362.76%-79.65% Do analysts prefer SNOA or WINT? Windtree Therapeutics has a consensus price target of $350.00, suggesting a potential upside of 21,241.46%. Given Windtree Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Windtree Therapeutics is more favorable than Sonoma Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sonoma Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Windtree Therapeutics 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the MarketBeat Community favor SNOA or WINT? Sonoma Pharmaceuticals received 213 more outperform votes than Windtree Therapeutics when rated by MarketBeat users. Likewise, 67.50% of users gave Sonoma Pharmaceuticals an outperform vote while only 42.86% of users gave Windtree Therapeutics an outperform vote. CompanyUnderperformOutperformSonoma PharmaceuticalsOutperform Votes21667.50% Underperform Votes10432.50% Windtree TherapeuticsOutperform Votes342.86% Underperform Votes457.14% Which has more risk & volatility, SNOA or WINT? Sonoma Pharmaceuticals has a beta of 1.56, meaning that its share price is 56% more volatile than the S&P 500. Comparatively, Windtree Therapeutics has a beta of 0.68, meaning that its share price is 32% less volatile than the S&P 500. Does the media refer more to SNOA or WINT? In the previous week, Windtree Therapeutics had 4 more articles in the media than Sonoma Pharmaceuticals. MarketBeat recorded 8 mentions for Windtree Therapeutics and 4 mentions for Sonoma Pharmaceuticals. Sonoma Pharmaceuticals' average media sentiment score of 0.71 beat Windtree Therapeutics' score of 0.69 indicating that Sonoma Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sonoma Pharmaceuticals 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Windtree Therapeutics 0 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummarySonoma Pharmaceuticals beats Windtree Therapeutics on 10 of the 16 factors compared between the two stocks. Remove Ads Get Windtree Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for WINT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart WINT vs. The Competition Export to ExcelMetricWindtree TherapeuticsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.23M$3.04B$5.65B$8.06BDividend YieldN/A1.54%4.57%4.01%P/E Ratio-0.1029.2923.1619.03Price / SalesN/A436.17386.8193.17Price / CashN/A168.6838.1634.64Price / Book0.163.956.914.33Net Income-$20.29M-$71.95M$3.20B$247.06M7 Day Performance10.81%-3.76%-2.30%-0.37%1 Month Performance-48.43%-10.33%2.86%-3.85%1 Year Performance-99.49%-27.15%10.51%1.27% Windtree Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)WINTWindtree Therapeutics2.5056 of 5 stars$1.64-3.5%$350.00+21,241.5%-99.5%$1.23MN/A-0.1030Short Interest ↓Gap DownSNOASonoma Pharmaceuticals0.3721 of 5 stars$3.23-7.2%N/A+1,644.4%$5.22M$13.97M-0.80180Short Interest ↑News CoverageENSCEnsysce Biosciences1.122 of 5 stars$3.65+5.8%N/A-74.3%$5.13M$2.23M-0.1310Short Interest ↓ONVOOrganovo1.0195 of 5 stars$2.99-4.8%N/A-80.4%$5.09M$122,000.00-3.5220Analyst ForecastStock SplitShort Interest ↓News CoveragePWUPPowerUp AcquisitionN/A$0.63-8.4%N/A-94.2%$4.90MN/A0.00N/AHigh Trading VolumeKZIAKazia Therapeutics2.915 of 5 stars$0.95-2.6%$11.50+1,110.4%-69.7%$4.79M$2.31M0.0012Short Interest ↑Gap UpCPHIChina PharmaN/A$0.24+3.1%N/A-23.4%$4.68M$5.54M0.00250CMNDClearmind Medicine0.7452 of 5 stars$1.10-2.2%N/A-9.5%$4.67MN/A-0.58N/AShort Interest ↓Gap UpADILAdial Pharmaceuticals2.8882 of 5 stars$0.71-3.8%$8.00+1,026.8%-53.6%$4.67MN/A-0.2120Short Interest ↓Gap DownAPMAptorum Group1.7083 of 5 stars$0.90-2.2%N/A-90.0%$4.66M$430,000.000.0030Short Interest ↓CELZCreative Medical Technology1.4095 of 5 stars$2.64-8.3%N/A-57.1%$4.62M$11,000.00-0.695Short Interest ↓High Trading Volume Remove Ads Related Companies and Tools Related Companies SNOA Competitors ENSC Competitors ONVO Competitors PWUP Competitors KZIA Competitors CPHI Competitors CMND Competitors ADIL Competitors APM Competitors CELZ Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:WINT) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Windtree Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Windtree Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy WINT Stock Free WINT Stock Alerts